Literature DB >> 9164051

G542X as a probable Phoenician cystic fibrosis mutation.

F Loirat1, S Hazout, G Lucotte.   

Abstract

When analyzed by origin, the frequency of the G542X cystic fibrosis (CF) mutation (the second most common CF mutation in Europe after DF508) varies between population groups in Europe. We show here that the frequency of G542X varies among different towns or regions of origin, being lower in northeastern Europeans than in southwestern Europeans. The G542X mutation mapping that we have defined by a multiple regression of G542X frequencies covers 28 countries (53 geographic points) and is based on data from 50 laboratories. The more elevated values of G542X frequency correspond to ancient sites of occupation by occidental Phoenicians.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164051

Source DB:  PubMed          Journal:  Hum Biol        ISSN: 0018-7143            Impact factor:   0.553


  4 in total

1.  A haplotype framework for cystic fibrosis mutations in Iran.

Authors:  Elahe Elahi; Ahmad Khodadad; Ilya Kupershmidt; Fereshteh Ghasemi; Babak Alinasab; Ramin Naghizadeh; Robert G Eason; Mahshid Amini; Mehran Esmaili; Mohammad R Esmaeili Dooki; Mohammad H Sanati; Ronald W Davis; Mostafa Ronaghi; Yvonne R Thorstenson
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

2.  Assessing the Disease-Liability of Mutations in CFTR.

Authors:  Claude Ferec; Garry R Cutting
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

3.  Detecting Common CFTR Mutations by Reverse Dot Blot Hybridization Method in Cystic Fibrosis First Report from Northern Iran.

Authors:  Mohammad-Reza Esmaeili Dooki; Haleh Akhavan-Niaki; Ali Ghabeli Juibary
Journal:  Iran J Pediatr       Date:  2011-03       Impact factor: 0.364

Review 4.  Arab gene geography: From population diversities to personalized medical genomics.

Authors:  Ghazi O Tadmouri; Konduru S Sastry; Lotfi Chouchane
Journal:  Glob Cardiol Sci Pract       Date:  2014-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.